| abstract |
This PPARĪ³ activating agent is characterized by containing a butenolide compound represented by expression (1), or a pharmaceutically permissible salt thereof. [In formula expression (1), R 1 is a hydrogen atom, a phosphate group, a fatty acid group, an alkyl group of 1-4 carbon atoms optionally and having a substituent, or a sugar residue optionally having a substituent, and R 2 is a phenyl group, a methyl phenyl group, a dimethyl phenyl group, an ethylphenyl group, a benzyl group, a methylbenzyl group, a dimethylbenzyl group, an ethyl benzyl group, a phenethyl group, a methylphenethyl group, a dimethyl phenethyl group or an ethyl phenethyl group.] |